APOE and cerebral amyloid angiopathy: Some other studies found that ε2 was also a risk factor of cognitive decline in T2DM4, 7, 8; consistently, ApoE ε2‐carriers showed increased risk of cerebral amyloid angiopathy, a cerebrovascular disorder caused by deposition of amyloid Aβ aggregates and correlates with presenile cognitive decline.27